Electronic Fetal Heart Rate (FHR) monitoring is recommended to assess fetal well-being during labour in high risk pregnancies. This Cardiotocograph (CTG) relies on the ultrasound technology with limitation of signal loss 15% 40% cases [1]. In earlier versions these CTG monitors, heart tracings were generally reasonable quality many artefacts and some degree occasional large noise. Subsequent mo...

In 1999, a highly publicized report from the Institute of Medicine identified major deficiencies in the United States health care system, which fueled the rapid growth of the modern patient safety movement. One of the greatest risks to patient safety in obstetrics is poor communication of electronic fetal heart rate monitoring findings. Standardization and elimination of unnecessary complexity ...

BACKGROUND Early diagnosis and risk stratification is of clinical importance in the long QT syndrome (LQTS), however, little genotype-specific data are available regarding fetal LQTS. We investigate third trimester fetal heart rate, routinely recorded within public maternal health care, as a possible marker for LQT1 genotype and phenotype. METHODS AND RESULTS This retrospective study includes...

We report cases of unexpected adverse fetal outcome from monitored labors in which the fetal heart rate tracing was interpreted as reassuring. In these cases, portions from another signal source, usually maternal, were imperceptibly substituted into the fetal tracing in a way that masked the evidence of fetal compromise.

The feasibility and accuracy of long-term transabdominal fetal electrocardiogram (fECG) recordings throughout pregnancy were studied using a portable fECG monitor. Fifteen-hour recordings of fetal heart rate (FHR) were performed in 150 pregnant women at 20-40 weeks of gestation and 1-hour recordings were performed in 22 women in labour and compared with simultaneous scalp electrode recordings. ...

OBJECTIVE To assess maternal rectal temperature and fetal heart rate responses to dynamic exercise. METHODS 11 healthy women with low risk pregnancies completed three separate upright cycling tests at 34 to 37 weeks gestation: 15 min at 62.5 W (mean maternal heart rate [MHR] 138 beats.min-1 (test A); 15 min at 87.5 W (MHR 156 beats.min-1) (test B); and 30 min at 62.5 W (MHR 142 beats.min-1) (...

The purpose of the study was to compare the accuracy of a noninvasive fetal heart rate monitor with that of ultrasound, using a fetal scalp electrode as the gold standard, in laboring women of varying body habitus, throughout labor and delivery. Laboring women requiring fetal scalp electrode were monitored simultaneously with the investigational device (noninvasive fetal ECG), ultrasound, and f...